
AP
CLEVELAND — The blockbuster trade, delayed and in jeopardy of dying, is done: Kyrie Irving is headed to the Celtics, Isaiah Thomas is coming to the Cavaliers and the NBA can take a well-earned break.
For a minute.
Concerned with medical findings after looking at Thomas’ injured right hip, the Cavs have negotiated another draft pick from Boston to compete the deal that had stalled, a person familiar with the negotiations told the Associated Press on Wednesday night.
Cleveland will get a second-round pick in 2020 to complete the package, said the person who spoke on condition of anonymity because the NBA has to sign off on the agreement.
ESPN first reported the deal was done.
The Cavs had balked at pushing the Aug. 22 trade through last week after Thomas underwent a physical. He tore a labrum last season in the playoffs against Cleveland, and it’s possible he might not be ready for the start of the season.
On Tuesday, Thomas told ESPN he is “not damaged” and believes he will return to All-Star form.
Irving demanded a trade in July and the Cavs pulled it off by sending their second-best player to the Celtics for Thomas, forward Jae Crowder, center Ante Zizic and an unconditional first-round pick next year.
The teams had deadline of 10 a.m. Thursday to agree on the trade.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less